Lumos Pharma, Inc. (LUMO) Misses Q1 EPS by 30c

Lumos Pharma, Inc. (NASDAQ: LUMO) reported Q1 EPS of ($1.29), $0.30 worse than the analyst estimate of ($0.99). Revenue for the quarter came in at $170 thousand versus the consensus estimate of $303.25 thousand.

For earnings history and earnings-related data on Lumos Pharma, Inc. (LUMO) click here.

You May Also Be Interested In

• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• IREN (IREN) Reiterated at Market Outperform by Citizens as Cloud Business Gains Momentum
• UBS Starts Yushu Technology Co (688836:CH) at Neutral